AQR Capital Management
CNST

AQR Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

AQR Capital Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,545
Closed -$361K – 2311
2020
Q4 		$361K Sell
12,545
-36,746
-75% -$925K ﹤0.01% 1895
2020
Q3 		$999K Buy
49,291
+1,354
+3% +$33.1K ﹤0.01% 1408
2020
Q2 		$1.44M Sell
47,937
-10,963
-19% -$395K ﹤0.01% 1307
2020
Q1 		$1.85M Buy
+58,900
New +$2.05M ﹤0.01% 1101

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AQR Capital Management's CNST Position: Q1 2021 in Review

AQR Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q1 2021, closing a stake of 12,545 shares — an estimated $361K sold.

AQR Capital Management first reported a position in CNST in Q1 2020 and held it in 4 quarters. The position peaked at $1.85M in Q1 2020. 131 funds tracked by Wall St. Rank hold CNST as of Q1 2021.

  • AQR Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • AQR Capital Management sold 12,545 Constellation Pharmaceuticals, Inc. shares in Q1 2021, an estimated $361K.
  • AQR Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 4 quarters.
  • AQR Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.85M in Q1 2020.
  • 131 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q1 2021.

Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.